AZ’s BTK cancer pill targets Imbruvica

By Megan Brodie 2 years ago | In Companies, Products
  • 2 years ago

31 January 2022 AstraZeneca’s CALQUENCE (acalabrutinib) will be expanded on the PBS from tomorrow (Tuesday)…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads